Mirae Asset debuts AI-recommended ETF on NYSE to invest in US bonds
Mirae Asset Financial Group, one of the largest asset managers in South Korea, has launched its first exchange-traded fund (ETF) investing in high-q...
Magnachip to sell display business in H1 to focus on power semiconductors
South Korean chipmaker Magnachip Semiconductor Corp. plans to sell its display business by the end of the first half as part of a strategic shift to...
South Korea’s Viva Republica drops Korean IPO plan, seeks US debut
Viva Republica Inc., a leading South Korean fintech unicorn and operator of mobile financial super app Toss, has dropped its plan to go public in th...
LG, Qraft Technologies' AI-powered ETF trades on NYSE
South Korea’s LG Group and Seoul-based Qraft Technologies Inc. have jointly launched an exchange-traded fund (ETF) that selects holdings relat...
NKMax to perform first tests on dementia cell therapy in US
NKMax Co., South Korea's largest developer of natural killer (NK) cell therapies, will conduct its first clinical trials in the US for its candidate...
NKMax's US subsidiary listed on Nasdaq
South Korean natural killer (NK) cell drugmaker NKMax Co. on Wednesday said its US subsidiary NKGen Biotech on Monday was listed on the Nasdaq Globa...
NKMax to supply health functional food to Chinese company
South Korean natural killer cell drug maker NKMax Co. announced in a regulatory filing on Friday that it has signed a supply contract with China's S...
NKMax submits US subsidiary's securities report to SEC
The listing in the US of NKGen Biotech, the American subsidiary of South Korean developer of natural killer (NK) cell therapy NKMax Co., is coming i...
US affiliate of Korea's cell therapy company NK Max eyes NYSE listing in 3Q
NKGen Biotech, the US affiliate of South Korea's natural killer (NK) cell therapy developer NK Max, on Friday said it signed a letter of intent (LOI) ...
S.Korean biotech NKMax’s unit aims for US IPO
NKMax Co., a South Korean cancer drug maker, is in talks with local and foreign investors in a bid to list its California-based unit NKGen Biotech I...
SK on eve of jackpot from NYSE debut of US battery maker SES
SK Inc., the investment-focused holding company of South Korea’s SK Group, is set to pocket a sixfold return from its investment in SES Holdin...
S.Korean millennials rush on Nasdaq and NYSE amid sluggish Kospi
South Korean millennials in their 20s and 30s are rushing to Nasdaq and the New York Stock Exchange (NYSE) amid skyrocketing real estate prices in t...
Coupang applies for IPO on New York Stock Exchange
Coupang Corp., 37% owned by SoftBank Group, is set to become the first Korean company to list directly on the New York Stock Exchange, with its valu...
